Literature DB >> 9009283

Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs.

S E Furesz1, B A Mallard, J T Bossé, S Rosendal, B N Wilkie, J I MacInnes.   

Abstract

Current porcine pleuropneumonia bacterins afford only partial protection by decreasing mortality but not morbidity. In order to better understand the type(s) of immune response associated with protection, antibody- and cell-mediated immune responses (CMIR) were compared for piglets before and after administration of a commercial bacterin, which confers partial protection, or a low-dose (10(5) CFU/ml) aerosol challenge with Actinobacillus pleuropneumoniae CM5 (LD), which induces complete protection. Control groups received phosphate-buffered saline or adjuvant. Serum antibody response, antibody avidity, delayed-type hypersensitivity (DTH), and lymphocyte blastogenic responses were measured and compared among treatment groups to the lipopolysaccharide (LPS), capsular polysaccharide (CPS), hemolysin (HLY), and outer membrane proteins (OMP) of A. pleuropneumoniae. Peripheral blood lymphocytes and sera were collected prior to and following primary and secondary immunization-infection and high-dose A. pleuropneumoniae CM5 (10(7) CFU/ml) aerosol challenge. Serum antibody and DTH, particularly that to HLY, differed significantly between treatment groups, and increases were associated with protection. LD-infected piglets had higher antibody responses (P < or = 0.01) and antibody avidity (P < or = 0.10) than bacterin-vaccinated and control groups. Anti-HLY antibodies were consistently associated with protection, whereas anti-LPS and anti-CPS antibodies were not. LD-infected animals had higher DTH responses, particularly to HLY, than bacterin-vaccinated pigs (P < or = 0.03). The LD-infected group maintained consistent blastogenic responses to HLY, LPS, CPS, and OMP over the course of infection, unlike the bacterin-vaccinated and control animals. These data suggest that the immune responses induced by a commercial bacterin are very different from those induced by LD aerosol infection and that current bacterins may be modified, for instance, by addition of HLY, so as to stimulate responses which better reflect those induced by LD infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009283      PMCID: PMC174603          DOI: 10.1128/iai.65.2.358-365.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Immunogenicity of Outer Membrane Components of Haemophilus (Actinobacillus) pleuropneumoniae.

Authors:  V J Rapp; R F Ross
Journal:  Can Vet J       Date:  1988-07       Impact factor: 1.008

2.  Reversal by interferon-gamma of inhibition of delayed-type hypersensitivity induction by anti-CD4 or anti-interleukin 2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role of the CD4+ TH1+ subset in mice.

Authors:  T Diamantstein; R Eckert; H D Volk; J W Kupier-Weglinski
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

3.  Enzyme immunoassay: observations on aspects of quality control.

Authors:  P Wright
Journal:  Vet Immunol Immunopathol       Date:  1987-12       Impact factor: 2.046

4.  Preliminary investigation of the mechanism of inhibition of bovine lymphocyte proliferation by Pasteurella haemolytica A1 leukotoxin.

Authors:  A L Majury; P E Shewen
Journal:  Vet Immunol Immunopathol       Date:  1991-08       Impact factor: 2.046

5.  The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.

Authors:  R B Markham; G B Pier; J R Schreiber
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

6.  Development and evaluation of a mixed-antigen ELISA for serodiagnosis of Actinobacillus pleuropneumoniae serotypes 1, 5, and 7 infections in commercial swine herds.

Authors:  J T Bossé; R Friendship; S Rosendal; B W Fenwick
Journal:  J Vet Diagn Invest       Date:  1993-07       Impact factor: 1.279

7.  Genetic and other effects on antibody and cell mediated immune response in swine leucocyte antigen (SLA)-defined miniature pigs.

Authors:  B A Mallard; B N Wilkie; B W Kennedy
Journal:  Anim Genet       Date:  1989       Impact factor: 3.169

8.  A model aerosol exposure system for induction of porcine Haemophilus pleuropneumonia.

Authors:  T N Sebunya; J R Saunders; A D Osborne
Journal:  Can J Comp Med       Date:  1983-01

9.  Vaccination against pleuropneumonia of pigs caused by Haemophilus pleuropneumoniae.

Authors:  S Rosendal; D S Carpenter; W R Mitchell; M R Wilson
Journal:  Can Vet J       Date:  1981-02       Impact factor: 1.008

10.  The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

Authors:  G Kaplan; R Kiessling; S Teklemariam; G Hancock; G Sheftel; C K Job; P Converse; T H Ottenhoff; M Becx-Bleumink; M Dietz
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  8 in total

1.  Urease activity may contribute to the ability of Actinobacillus pleuropneumoniae to establish infection.

Authors:  J T Bossé; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Comparative pathogenicity of different Actinobacillus suis O/K serotypes.

Authors:  D Slavić; J DeLay; M A Hayes; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

3.  Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.

Authors:  C T Prideaux; C Lenghaus; J Krywult; A L Hodgson
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Effect of reducing the ratio of omega-6-to-omega-3 fatty acids in diets of low protein quality on nursery pig growth performance and immune response.

Authors:  Lee-Anne Huber; Seema Hooda; Rebecca E Fisher-Heffernan; Niel A Karrow; Cornelis F M de Lange
Journal:  J Anim Sci       Date:  2018-09-29       Impact factor: 3.159

5.  The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.

Authors:  Shulin Fu; Jiwen Ou; Minmin Zhang; Juan Xu; Huazhen Liu; Jinlin Liu; Fangyan Yuan; Huanchun Chen; Weicheng Bei
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

6.  Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.

Authors:  Meili Shao; Yong Wang; Chunlai Wang; Yang Guo; Yonggang Peng; Jiandong Liu; Guangxing Li; Huifang Liu; Siguo Liu
Journal:  Acta Vet Scand       Date:  2010-09-11       Impact factor: 1.695

7.  Identification of Actinobacillus pleuropneumoniae genes important for survival during infection in its natural host.

Authors:  Brian J Sheehan; Janine T Bossé; Amanda J Beddek; Andrew N Rycroft; J Simon Kroll; Paul R Langford
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Frequency of Th17 cells correlates with the presence of lung lesions in pigs chronically infected with Actinobacillus pleuropneumoniae.

Authors:  Elena L Sassu; Andrea Ladinig; Stephanie C Talker; Maria Stadler; Christian Knecht; Heiko Stein; Janna Frömbling; Barbara Richter; Joachim Spergser; Monika Ehling-Schulz; Robert Graage; Isabel Hennig-Pauka; Wilhelm Gerner
Journal:  Vet Res       Date:  2017-02-06       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.